• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体/髓样分化因子88介导的肠道移植物抗宿主病中的固有免疫

TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease.

作者信息

Lee Young-Kwan, Kang Myungsoo, Choi Eun Young

机构信息

Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.

BioMembrane Plasticity Research Center (MPRC), Seoul National University College of Medicine, Seoul 03080, Korea.

出版信息

Immune Netw. 2017 Jun;17(3):144-151. doi: 10.4110/in.2017.17.3.144. Epub 2017 Jun 20.

DOI:10.4110/in.2017.17.3.144
PMID:28680375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5484644/
Abstract

Graft-versus-host disease (GHVD) is a severe complication after allogeneic hematopoietic stem cell transplantation. The degree of inflammation in the gastrointestinal tract, a major GVHD target organ, correlates with the disease severity. Intestinal inflammation is initiated by epithelial damage caused by pre-conditioning irradiation. In combination with damages caused by donor-derived T cells, such damage disrupts the epithelial barrier and exposes innate immune cells to pathogenic and commensal intestinal bacteria, which release ligands for Toll-like receptors (TLRs). Dysbiosis of intestinal microbiota and signaling through the TLR/myeloid differentiation primary response gene 88 (MyD88) pathways contribute to the development of intestinal GVHD. Understanding the changes in the microbial flora and the roles of TLR signaling in intestinal GVHD will facilitate the development of preventative and therapeutic strategies.

摘要

移植物抗宿主病(GVHD)是异基因造血干细胞移植后的一种严重并发症。胃肠道作为主要的移植物抗宿主病靶器官,其炎症程度与疾病严重程度相关。肠道炎症由预处理放疗引起的上皮损伤引发。这种损伤与供体来源的T细胞造成的损伤共同作用,破坏上皮屏障,使天然免疫细胞暴露于致病性和共生性肠道细菌,这些细菌释放Toll样受体(TLR)的配体。肠道微生物群失调以及通过TLR/髓样分化初级反应基因88(MyD88)途径的信号传导促成了肠道移植物抗宿主病的发展。了解肠道微生物群的变化以及TLR信号在肠道移植物抗宿主病中的作用将有助于制定预防和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7702/5484644/b4c0d4d15c41/in-17-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7702/5484644/b4c0d4d15c41/in-17-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7702/5484644/b4c0d4d15c41/in-17-144-g001.jpg

相似文献

1
TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease.Toll样受体/髓样分化因子88介导的肠道移植物抗宿主病中的固有免疫
Immune Netw. 2017 Jun;17(3):144-151. doi: 10.4110/in.2017.17.3.144. Epub 2017 Jun 20.
2
Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.宿主 MyD88 信号转导在异基因骨髓移植后可预防急性移植物抗宿主病。
Clin Exp Immunol. 2019 Jan;195(1):121-131. doi: 10.1111/cei.13215. Epub 2018 Oct 14.
3
Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD.固有免疫与移植耐受:Toll样受体/核苷酸结合寡聚化结构域样受体在移植物抗宿主病中的潜在作用
Korean J Hematol. 2011 Jun;46(2):69-79. doi: 10.5045/kjh.2011.46.2.69. Epub 2011 Jun 21.
4
Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.微小 RNA 对急性移植物抗宿主病的 Toll 样受体的刺激作用。
Front Immunol. 2018 Nov 5;9:2561. doi: 10.3389/fimmu.2018.02561. eCollection 2018.
5
Attenuation of Hepatic Graft-versus-host Disease in Allogeneic Recipients of MyD88-deficient Donor Bone Marrow.MyD88缺陷型供体骨髓同种异体受体中肝移植物抗宿主病的减轻
Immune Netw. 2015 Jun;15(3):125-34. doi: 10.4110/in.2015.15.3.125. Epub 2015 Jun 25.
6
Commensal and Pathogenic Biofilms Alter Toll-Like Receptor Signaling in Reconstructed Human Gingiva.共生和病原生物膜改变重建人牙龈中的 Toll 样受体信号转导。
Front Cell Infect Microbiol. 2019 Aug 7;9:282. doi: 10.3389/fcimb.2019.00282. eCollection 2019.
7
Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT.通过一种新型 MyD88 抑制剂调节 TIR 结构域的构象,可将移植物抗宿主病(GVHD)与移植物抗白血病(GVL)分离。
Leuk Lymphoma. 2019 Jun;60(6):1528-1539. doi: 10.1080/10428194.2018.1537487. Epub 2018 Dec 3.
8
Myeloid differentiation factor 88 signaling in donor T cells accelerates graft--host disease.供体T细胞中的髓样分化因子88信号传导会加速移植物抗宿主病。
Haematologica. 2020 Jan;105(1):226-234. doi: 10.3324/haematol.2018.203380. Epub 2019 May 2.
9
The Role of Intestinal Microbiota in Graft versus Host Disease.肠道微生物群在移植物抗宿主病中的作用。
Mini Rev Med Chem. 2015;16(3):193-9. doi: 10.2174/1389557515666150722110547.
10
Intestinal microbiota-related effects on graft-versus-host disease.肠道微生物群对移植物抗宿主病的相关影响。
Int J Hematol. 2015 May;101(5):428-37. doi: 10.1007/s12185-015-1781-5. Epub 2015 Mar 27.

引用本文的文献

1
G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor .G-四链体和i-基序DNA结构在关键天然免疫衔接蛋白的启动子中形成。
Cell Rep Phys Sci. 2025 May 21;6(5). doi: 10.1016/j.xcrp.2025.102560. Epub 2025 Apr 28.
2
Extract of Ellis Attenuates High-Fat Diet-Induced Glycolipid Metabolism Disorder in Rats by Targeting Gut Microbiota and TLR4/Myd88/NF-κB Pathway.埃利斯提取物通过靶向肠道微生物群和TLR4/Myd88/NF-κB通路减轻高脂饮食诱导的大鼠糖脂代谢紊乱
Antioxidants (Basel). 2024 Feb 28;13(3):293. doi: 10.3390/antiox13030293.
3
Hippo pathway in intestinal diseases: focusing on ferroptosis.

本文引用的文献

1
Revised Estimates for the Number of Human and Bacteria Cells in the Body.人体和细菌细胞数量的修订估计值。
PLoS Biol. 2016 Aug 19;14(8):e1002533. doi: 10.1371/journal.pbio.1002533. eCollection 2016 Aug.
2
Effect of upregulated TLR2 expression from G-CSF-mobilized donor grafts on acute graft-versus-host disease.粒细胞集落刺激因子动员的供体移植物中上调的Toll样受体2表达对急性移植物抗宿主病的影响
Int Immunopharmacol. 2015 Dec;29(2):488-493. doi: 10.1016/j.intimp.2015.10.007. Epub 2015 Oct 20.
3
MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.
肠道疾病中的Hippo信号通路:聚焦铁死亡
Front Cell Dev Biol. 2023 Dec 6;11:1291686. doi: 10.3389/fcell.2023.1291686. eCollection 2023.
4
Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review).释放自然的潜力与局限:探索治疗多发性硬化症的分子靶向途径及安全替代方案(综述)
Med Int (Lond). 2023 Aug 17;3(5):42. doi: 10.3892/mi.2023.102. eCollection 2023 Sep-Oct.
5
Effects of Lysophosphatidylcholine on Jejuna Morphology and Its Potential Mechanism.溶血磷脂酰胆碱对空肠形态的影响及其潜在机制
Front Vet Sci. 2022 Jun 20;9:911496. doi: 10.3389/fvets.2022.911496. eCollection 2022.
6
Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后的肠道微生物群调节与粪便微生物群移植
Cancers (Basel). 2021 Sep 17;13(18):4665. doi: 10.3390/cancers13184665.
7
IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.IDO1 清除髓系来源的抑制细胞中的活性氧物质,以预防移植物抗宿主病。
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2011170118.
8
Flavonoids: Nutraceuticals for Rheumatic Diseases via Targeting of Inflammasome Activation.类黄酮:通过靶向炎症小体激活治疗风湿性疾病的营养保健品。
Int J Mol Sci. 2021 Jan 6;22(2):488. doi: 10.3390/ijms22020488.
9
Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures.异基因干细胞移植相关性急性移植物抗宿主病:基于口腔和肠道微生物组特征的计算药物发现文本挖掘方法。
Support Care Cancer. 2021 Apr;29(4):1765-1779. doi: 10.1007/s00520-020-05821-2. Epub 2020 Oct 22.
10
[Over-expression of miR-144 inhibits invasion of liver cancer SMMC-7721 cells by suppressing TLR/MyD88 pathway].[miR-144过表达通过抑制TLR/MyD88通路抑制肝癌SMMC-7721细胞侵袭]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 May 30;40(5):765-771. doi: 10.12122/j.issn.1673-4254.2020.05.25.
供体骨髓细胞中的髓样分化因子88对于预防急性肠道移植物抗宿主病至关重要。
Mucosal Immunol. 2016 May;9(3):730-43. doi: 10.1038/mi.2015.96. Epub 2015 Oct 7.
4
GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.移植物抗宿主病相关的、炎性小体介导的过继转移骨髓来源抑制细胞功能丧失。
Blood. 2015 Sep 24;126(13):1621-8. doi: 10.1182/blood-2015-03-634691. Epub 2015 Aug 11.
5
In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity.体外生成的髓源性抑制细胞通过诱导 2 型 T 细胞而不削弱抗肿瘤细胞毒性来预防小鼠移植物抗宿主病。
Blood. 2015 Aug 27;126(9):1138-48. doi: 10.1182/blood-2015-01-624163. Epub 2015 Jul 16.
6
Attenuation of Hepatic Graft-versus-host Disease in Allogeneic Recipients of MyD88-deficient Donor Bone Marrow.MyD88缺陷型供体骨髓同种异体受体中肝移植物抗宿主病的减轻
Immune Netw. 2015 Jun;15(3):125-34. doi: 10.4110/in.2015.15.3.125. Epub 2015 Jun 25.
7
Role of myeloid-derived suppressor cells in autoimmune disease.髓源性抑制细胞在自身免疫性疾病中的作用。
World J Immunol. 2014 Mar 27;4(1):26-33. doi: 10.5411/wji.v4.i1.26.
8
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:I. 2014年诊断与分期工作组报告
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.
9
Editorial: the contribution of myeloid-derived suppression to inflammatory disease.社论:髓源性抑制对炎症性疾病的作用
J Leukoc Biol. 2014 Sep;96(3):361-4. doi: 10.1189/jlb.3CE0414-205R.
10
Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.髓源性抑制细胞的功能及其与利什曼原虫的相互作用在 C57BL/6 和 BALB/c 小鼠中存在差异。
Eur J Immunol. 2014 Nov;44(11):3295-306. doi: 10.1002/eji.201344335. Epub 2014 Sep 19.